Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Bio-Techne Dividend Announcement
• Bio-Techne announced a quarterly dividend of $0.08 per ordinary share which will be made payable on 2024-11-22. Ex dividend date: 2024-11-08
• Bio-Techne annual dividend for 2024 was $0.32
• Bio-Techne annual dividend for 2023 was $0.32
• Bio-Techne's trailing twelve-month (TTM) dividend yield is 0.43%
• Bio-Techne's payout ratio for the trailing twelve months (TTM) is 33.48%
• Bio-Techne's dividend growth over the last five years (2018-2023) was -24.21% year
• Bio-Techne's dividend growth over the last ten years (2013-2023) was -12.45% year
Bio-Techne Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-08 | $0.08 | quarterly | 2024-11-22 |
2024-08-19 | $0.08 | quarterly | 2024-08-30 |
2024-05-10 | $0.08 | quarterly | 2024-05-24 |
2024-02-09 | $0.08 | quarterly | 2024-02-26 |
2023-11-09 | $0.08 | quarterly | 2023-11-24 |
2023-08-17 | $0.08 | quarterly | 2023-09-01 |
2023-05-12 | $0.08 | quarterly | 2023-05-26 |
2023-02-10 | $0.08 | quarterly | 2023-02-27 |
2022-11-10 | $0.32 | quarterly | 2022-11-28 |
2022-08-12 | $0.32 | quarterly | 2022-08-29 |
2022-05-13 | $0.32 | quarterly | 2022-05-27 |
2022-02-10 | $0.32 | quarterly | 2022-02-25 |
2021-11-10 | $0.32 | quarterly | 2021-11-26 |
2021-08-13 | $0.32 | quarterly | 2021-08-27 |
2021-05-14 | $0.32 | quarterly | 2021-05-28 |
2021-02-11 | $0.32 | quarterly | 2021-02-26 |
2020-11-13 | $0.32 | quarterly | 2020-11-27 |
2020-08-17 | $0.32 | quarterly | 2020-08-28 |
2020-05-08 | $0.32 | quarterly | 2020-05-22 |
2020-02-13 | $0.32 | quarterly | 2020-02-28 |
2019-11-07 | $0.32 | quarterly | 2019-11-22 |
2019-08-15 | $0.32 | quarterly | 2019-08-30 |
2019-05-09 | $0.32 | quarterly | 2019-05-24 |
2019-02-14 | $0.32 | quarterly | 2019-03-01 |
2018-11-08 | $0.32 | quarterly | 2018-11-23 |
2018-08-16 | $0.32 | quarterly | 2018-08-31 |
2018-05-11 | $0.32 | quarterly | 2018-05-25 |
2018-02-15 | $0.32 | quarterly | 2018-03-02 |
2017-11-09 | $0.32 | quarterly | 2017-11-24 |
2017-08-16 | $0.32 | quarterly | 2017-09-01 |
2017-05-17 | $0.32 | quarterly | 2017-06-02 |
2017-02-15 | $0.32 | quarterly | 2017-03-03 |
2016-11-09 | $0.32 | quarterly | 2016-11-28 |
2016-08-25 | $0.32 | quarterly | 2016-09-12 |
2016-05-11 | $0.32 | quarterly | 2016-05-27 |
2016-02-10 | $0.32 | quarterly | 2016-02-26 |
2015-11-10 | $0.32 | quarterly | 2015-11-27 |
2015-08-13 | $0.32 | quarterly | 2015-08-28 |
2015-05-13 | $0.32 | quarterly | 2015-05-29 |
2015-02-11 | $0.32 | quarterly | 2015-02-27 |
2014-11-06 | $0.32 | quarterly | 2014-11-24 |
2014-08-19 | $0.31 | quarterly | 2014-08-29 |
2014-05-07 | $0.31 | quarterly | 2014-05-23 |
2014-02-12 | $0.31 | quarterly | 2014-02-28 |
2013-11-07 | $0.31 | quarterly | 2013-11-25 |
2013-08-14 | $0.30 | quarterly | 2013-08-30 |
2013-05-08 | $0.30 | quarterly | 2013-05-24 |
2013-02-13 | $0.30 | quarterly | 2013-03-01 |
Bio-Techne Dividend per year
Bio-Techne Dividend growth
Bio-Techne Dividend Yield
Bio-Techne current trailing twelve-month (TTM) dividend yield is 0.43%. Interested in purchasing Bio-Techne stock? Use our calculator to estimate your expected dividend yield:
Bio-Techne Financial Ratios
Bio-Techne Dividend FAQ
Other factors to consider when evaluating Bio-Techne as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bio-Techne stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bio-Techne's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bio-Techne publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bio-Techne distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bio-Techne are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bio-Techne sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bio-Techne distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bio-Techne declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bio-Techne's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bio-Techne's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.